Text Size

Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study

Chia A, Ngo C, Choudry N, Yamakawa Y, Tan D


  • 2023
  • Asia Pac J Ophthalmol (Phila)
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Clinical development

  • Affiliations

    Singapore National Eye Centre, Singapore, Singapore; Department of Ophthalmology, National University Hospital, Singapore, Singapore; Santen Canada Inc., Toronto, ON, Canada; Santen Pharmaceuticals Co. Ltd, Osaka, Japan; Eye and Retina Surgeons, Camden Medical Center, Singapore, Singapore

Related Publications

Functional significance of commonly regulated genes in mechanically and chemically induced retinal ganglion cell death in rat eyes

Kageyama M, Ohashi K, Ota T.


Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy

Kikkawa C., Ikeda H.O., Hata M., Iwai S., Tsujikawa A.


Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction

Matsushita T.; Onishi A.; Matsuyama T.; Masuda T.; Ogino Y.; Kageyama M.; Takahashi M.; Uchiumi F.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022